Abstract-Little is known regarding the molecular mechanisms of atherogenicity of triglyceride-rich lipoproteins such as very low-density lipoproteins (VLDLs). We examined the effect of VLDL on proliferation of rat aortic smooth muscle cells, intracellular Ca 2ϩ handling, and activity of cAMP-responsive element binding protein (CREB) and nuclear factor of activated T cells (NFAT) transcription factors. VLDL, isolated from human serum, dose-and time-dependently promoted proliferation. After 4 hours of exposure to VLDL (0.15 g/L proteins), the caffeine-induced Ca 2ϩ release was inhibited and the IP3-sensitive Ca 2ϩ release induced by ATP (10 mol/L) was markedly prolonged. In quiescent cells, CREB was phosphorylated (pCREB) and NFAT was present in the cytosol, whereas in cells exposed to VLDL for 4 to 24 hours, pCREB disappeared and NFAT was translocated to the nucleus. VLDL-induced NFAT translocation and proliferation were blocked by cyclosporin A and LY294002 involving calcineurin and phosphatidylinositol 3-kinase (PI3K) pathways. Indeed, VLDLs rapidly phosphorylate protein kinase B and glycogen synthase kinase-3␤ in a PI3K-dependent way. These results provide the first evidence that VLDLs induce smooth muscle cell proliferation by activating the PI3K pathway and nuclear NFAT translocation. Blockade of the Ca 2ϩ -induced Ca 2ϩ release mechanism and dephosphorylation of pCREB contribute but were not sufficient to induce a proliferating phenotype. 
H ypertriglyceridemia is considered an independent risk factor of atherosclerosis and coronary disease, 1,2 but the mechanisms of atherogenicity are not clearly defined. An increasing body of evidence supports multiple roles for very low-density lipoproteins (VLDLs), the main carriers of triglycerides, in the development of atherosclerosis and cardiovascular diseases. The VLDLs may have an indirect role because of the strong relationship between elevated triglycerides and other atherogenic metabolic changes, including decreased levels of high-density lipoprotein (HDL) and a predominance of atherogenic small and dense low-density lipoprotein (LDL) particles. They may also have a direct influence on atherosclerosis by altering physiological functions of arterial wall cells. 2, 3 A potential relationship between hypertriglyceridemia and disease progression has been suggested in studies showing that atherogenic lipoproteins induce smooth muscle cell (SMC) proliferation, a phenomenon of primary importance in atherosclerosis, restenosis after balloon injury, or neointimal occlusion of grafts. How hypertriglyceridemia alters vascular cells toward the atherosclerotic phenotype is still under intense investigation. Previous studies showed that VLDL stimulated SMC DNA replication and growth by themselves 4, 5 via activation of the mitogenactivated protein kinase (MAPK) extracellular signal-regulated kinase (ERK1) and ERK2. 5 ␤VLDL, a cholesteryl ester-rich atherogenic lipoprotein, alone was unable to inspire quiescent cells into S phase but activated ERK1/ERK2 via transactivation of the epidermal growth factor receptor. 6 Furthermore, recent clinical trials have provided evidence that calcium channel blockers can inhibit progression of atherosclerotic disease. 7, 8 Ca 2ϩ is an essential regulator of the cell cycle and the Ca 2ϩ response amplitude and duration control gene expression in various cell types. 9 Proliferation of SMCs is accompanied by modifications in calcium homeostasis and expression of genes encoding Ca 2ϩ transporting proteins. Indeed, decreased L-type and enhanced T-type Ca 2ϩ channel activity 10 -12 as well as enhanced capacitative Ca 2ϩ entry 13 and upregulation of the TRP1 channels 14 were described in proliferating SMCs. We also demonstrated that the ryanodine receptor (RyR) and the sarcoplasmic reticulum Ca 2ϩ -ATPase, SERCA 2a, were lost in proliferating cells. 15 Similar changes were observed under chronic exposure of SMCs to minimally oxidized LDL. 16, 17 Two main Ca 2ϩ -regulated transcription factors were described: c-AMP responsive element binding protein (CREB) and nuclear factor of activated T-cells (NFAT). Transient Ca 2ϩ influx through the L-type voltage-activated channels is particularly effective at activating CREB via Ca 2ϩ /CaMdependent phosphorylation by Ca 2ϩ /calmodulin kinase or MAPK. 18 -20 By contrast, a sustained increase in cytosolic Ca 2ϩ , obtained for example by PDGF activation of IP3R, is necessary to dephosphorylate NFAT by calcineurin, a Ca 2ϩ / calmodulin-dependent phosphatase, and induce its translocation into the nucleus. 21, 22 GSK-3␤ is a negative regulator of this signaling pathway because it phosphorylates NFAT and induces its export from the nucleus. Inactivation of GSK-3␤ by phosphorylation on Ser9 by protein kinase B (also called Akt) is necessary to assure NFAT-dependent transcription. Akt itself is activated by the phosphatidylinositol 3-kinase (PI3K). Very recently, by using VLDL receptor-deficient mice, Beffert at al 23 demonstrated that in cultured embryonic neurons, the VLDL receptor is coupled to the PI3K-dependent signaling cascade.
We designed experiments to determine whether VLDL could induce proliferation of isolated rat aortic SMCs in culture or could alter Ca 2ϩ homeostasis and the activation of Ca 2ϩ -regulated transcription factors to induce a new gene expression program characteristic of the proliferating SMC. We analyzed the pathways involved in these processes.
Materials and Methods

Preparation and Characterization of VLDLs
Total plasma was recovered from normotriglyceridemic donors free from infectious disease, with prior consent and following the local ethic committee guidelines. VLDLs (density (d) Ͻ1.006 g/mL) and HDL (1.063 Ͻd Ͻ1.210 g/mL) were prepared by sequential ultracentrifugation. 24 For detailed characterization, please refer to the expanded Materials and Methods section, available in the online data supplement at http://www.circresaha.org.
Isolation and Culture of SMCs: Analysis of Cell Proliferation
Rat aortic SMCs were isolated from the media of the thoracic aorta from male Wistar rats as described. 15 All experiments were performed on primary culture. After dissociation, cells were allowed to adhere for 24 hours in DMEM supplemented with 1% penicillinstreptomycin-amphotericin mixture (ICN) and 20% FCS and then maintained for 24 to 36 hours in 0.1% FCS medium before beginning the experiments. For the experiment, the medium was replaced by DMEM containing either 0.1% lipoprotein-deprived FCS (LPDS) with or without purified VLDL or 10% FCS. The concentration of VLDL vehicle (PBS) was kept constant in all compared cultures. Various components were added together with the VLDL fraction to analyze their influence on proliferation; LY294002 (No. 9901, Cell Signaling), diltiazem, ryanodine, cyclosporin A (CsA), and rapamycin were from Sigma.
Proliferation of SMCs was measured by using the colorimetricbased CellTiter96 Cell Proliferation Assay kit (Promega) according to manufacturer instructions.
Reverse Transcriptase-Polymerase Chain Reaction for NFAT Isoforms
Total RNA was prepared from aorta or cultured SMCs by using the RNAxis Reagent (Genaxis) according to the manufacturer's protocol. Reverse transcriptase-polymerase chain reaction (RT-PCR) was performed as described. 21 Amplified PCR products were separated by agarose gel electrophoresis and detected by ethidium bromide staining.
Western Blot Analysis and Immunofluorescence
Total cell lysates were prepared according to standard protocol (Upstate Biotechnology). Cytosolic and nuclear fractions were obtained by hypotonic lysis as described. 25 The primary antibodies were anti-phosphorylated CREB (apCREB) and a-CREB from Upstate Biotechnology (Nos. 06-519 and 06-863); a-NFATc1 and a-NFATc3 from Santa Cruz Biotechnology, Inc (K-18 and M-75); a-pAkt, a-Akt, a-pGSK-3␤, a-pPTEN, a-pPDK1, and a-FKHR from Cell Signaling (No. 9916) and a-p53. 26 Proteins were visualized using the enhanced chemiluminescence detection system (ECLϩ, Amersham).
For immunofluorescence, proteins were visualized by using either secondary antibodies directly conjugated to Texas Red or the biotin/streptavidin-Texas Red conjugated amplification method (Amersham). Antibodies to RyR and to SERCA 2a and 2b were previously described. 27, 28 Anti-PCNA (proliferating nuclear antigen) was from Dako-France. Nuclei were stained with Hoechst (Sigma). Images were collected with a Zeiss LSM-510 confocal scanning laser microscope as described online in the expanded Materials and Methods section. 
Statistical Analysis
All quantitative data are presented as mean of at least 3 independent experimentsϮSEM. Data were analyzed by using the SigmaStat Statistical Software Package, version 2.0 (Jandel Scientific). Oneway ANOVA or Kruskal-Wallis ANOVA on ranks followed by the Dunn's or Tukey method was performed for multiple comparison of values. Statistical comparison of 2 values was done by an unpaired Student's t test. PϽ0.05 was considered to be statistically significant. An expanded Materials and Methods section can be found in the online data supplement available at http://www.circresaha.org.
Results
VLDLs Stimulate Proliferation of SMCs in a Doseand Time-Dependent Manner
Exposure of rat aortic SMCs to VLDL significantly promoted cell proliferation in a concentration-dependent ( Figure 1A ) and time-dependent ( Figure 1B ) manner. The maximal response was observed with 0.15 g protein/L (1 mmol/L triglycerides). The number of cells in VLDL-treated culture was significantly increased after 24 hours, and saturation was reached at 48 hours. Proliferation was increased by Ϸ2.5-fold compared with control cells cultured in 0.1% LPDS. Similar levels of proliferation were obtained with VLDL (0.15 g/L) and 10% FCS. HDL isolated from the same plasma never enhanced proliferation, even at high dose.
The cells in 0.1% FCS expressed SERCA 2a, SERCA 2b, and the RyR. PCNA was not detected in the nucleus, attesting for a quiescent/differentiated phenotype (online Figure 1) . In the presence of VLDL for 2 or 3 days, PCNA was present in the nucleus, indicating that cells were proliferating. SERCA 2a and the RyR were absent, whereas SERCA 2b was still expressed, as already described in dedifferentiated SMCs. 15 
VLDLs Alter [Ca 2؉ ] i Transient
We tested the hypothesis that VLDLs could alter Ca 2ϩ release through the RyR or the IP3R by analyzing the caffeine-or ATP-induced Ca 2ϩ transients, respectively. In control conditions, SMCs were sensitive to both caffeine and ATP (Figure 2A 
CREB Phosphorylation Is Decreased in VLDL-Treated SMCs
Most of the nuclei of control SMCs (0.1% LPDS) and of cells incubated with VLDL for 4 hours were stained with anti-pCREB ( Figure 3A) . However, the number of pCREB-positive nuclei was dramatically decreased after 24 hours with VLDL. The level of CREB phosphorylation was quantitated by Western blotting using anti-pCREB and a-CREB sequentially after stripping ( Figure 3B ). The level of CREB was similar in all samples. The ratio of pCREB/CREB was decreased Ͼ50% in the presence of VLDL (1 mmol/L triglycerides) for 24 or 48 hours or 10% FCS for 48 hours compared with control conditions (0.1% LPDS) or VLDL for 4 hours. Because pCREB regulates expression of the tumor suppressor gene, p53, 29 we analyzed the level of p53 after VLDL treatment ( Figure 3C ). No variation was observed after 4 hours with VLDL, but after 48 hours p53 expression was lowered.
VLDLs Activate the NFAT Pathway
The NFAT isoform expressed in rat aortic SMCs was determined by RT-PCR ( Figure 4A ). Only NFATc3 (NFAT4) was detected in aorta free of endothelium and adventitia as well as in SMCs maintained in presence of 0.1% LPDS for 24 hours. NFATc4 (NFAT3) transcript was induced by exposure to VLDL or 10% FCS for 72 hours, and trace amounts of NFATp (NFAT2) were induced in cells exposed to 10% FCS for 72 hours. Because NFAT is transcriptionally active only when it is in the nucleus, we analyzed the localization of NFAT protein by immunofluorescence ( Figure 4B ) and by Western blot of nuclear extracts ( Figure 4C ). Both the specific a-NFATc3 antibody and an a-NFAT antibody that recognized all NFAT isoforms (data not shown) were used for immunofluorescence with the same results. In control cells (Figure 4Ba ), NFAT was located in the cytosol, whereas NFAT staining was more abundant in the nuclei after exposure to VLDL for 24 hours (Figure 4Bb ). In cells exposed to VLDL for 24 hours in the presence of the calcineurin inhibitor CsA (5 mol/L), NFAT was arrested in the cytosol (Figure 4Bc ), as expected. In the presence of LY294002 (10 mol/L), an inhibitor of PI3K, NFAT was mainly in the cytosol (Figure 4Bd ), suggesting that VLDL activated the PI3K pathway. Western blot analysis of total extracts from freshly isolated cells using the common a-NFAT antibody (not shown) revealed only 1 NFAT protein (110 to 115 kDa) corresponding to NFATc3. In nuclear extracts, the amount of NFATc3 was increased after exposure to VLDL for 24 hours or after exposure to 10% FCS for 24 hours ( Figure 4C ). CsA blocked NFAT transport into the nucleus. Thus, VLDLs activate NFAT translocation in a calcineurin-dependent and PI3 kinase-dependent way.
Pharmacological Analysis of the Calcium Signaling Pathways Involved in VLDL-Induced CML Proliferation
To determine the importance of CREB and NFAT pathways on VLDL-induced proliferation, we tested the effect of various drugs known to act on these pathways ( Figure 5 ). Ca 2ϩ influx through L-type channels was shown to be essential in CREB phosphorylation, 18 but diltiazem (still active in presence of VLDL, Figure 2C ) had no effect on VLDL-induced proliferation. Ryanodine did not influence VLDL-induced proliferation, in agreement with the data in Figure 2 , showing that the caffeine-induced Ca 2ϩ release was already inhibited by VLDL. Rapamycin, a drug known to block proliferation by acting on mTOR (mammalian target of rapamycin), completely blocked VLDL-induced proliferation at picomolar concentrations. Cyclosporin A (5 mol/L) and LY294002 (10 mol/L) prevented VLDL-induced proliferation at doses that also prevented NFAT translocation. These latter data suggest that there is a relationship between NFAT translocation and proliferation and that activation of the PI3 kinase is involved in both processes.
VLDLs Activate the PI3K Signaling Cascade
Thus, we analyzed the effect of VLDL (1 mmol/L triglycerides) on the PI3K signaling cascade by Western blot ( Figure  6 ). A 30-minute exposure to VLDL induced phosphorylation of Akt on Thr308 and Ser473, and phosphorylation was maintained for up to 24 hours. The level of total Akt was stable. We also tested phosphorylation of 2 of the targets of The membranes were probed with a-pAkt (Thr308), a-pAkt (Ser473), a-pGSK-3␤ (Ser9), or a-p-FKHR (Ser256). Then they were stripped and probed with a-Akt, a-pPTEN (Ser380), and a-pPDK (Ser241), confirming equivalent protein loading.
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Akt, GSK3-␤ on Ser9 and FKHR (a forkhead transcription factor) on Ser256. Both were phosphorylated within 30 minutes after application of VLDL. Phosphorylation of FKHR was transient, whereas that of GSK3-␤ was additionally increased after 24 hours. Phosphorylation was abolished or markedly decreased by LY294002 (10 mol/L), indicating that PI3K is involved in this process. The levels of phospho-PTEN (Ser380) and of phospho-PDK1 (Ser241), as expected, were insensitive to LY294002. These results demonstrate that VLDLs activate the Akt pathway through activation of the PI3 kinase.
Discussion
Results of the present study provide evidence that VLDLs induce proliferation of rat aortic smooth muscle cells by activating the PI3 kinase/Akt pathway leading to NFAT nuclear translocation. Furthermore, VLDLs inhibit the ryanodine-sensitive store and CREB phosphorylation, additionally contributing to induce a proliferating phenotype. LDLs, either native or mildly oxidized, were clearly shown to be mitogenic for vascular SMCs, 6, 30 but the effect of VLDL, a triglyceride-rich lipoprotein, was more controversial. In agreement with our results, VLDLs were shown to promote proliferation of human or rat arterial SMCs by themselves. 4, 5 However, ␤VLDL, a cholesteryl ester-rich atherogenic lipoprotein, did not induce proliferation of quiescent smooth muscle cells alone but increased the proliferative rate of actively dividing cells and exacerbated the effect of epidermal growth factor. 6 Yet it was not clear how lipoproteins, and especially VLDL, exert their proliferating effect.
In the present study, we demonstrate that VLDLs induce rapid (30-minute) phosphorylation of Akt and of its downstream targets GSK-3␤ and FKHR. Phosphorylation of FKHR regulates its nuclear translocation and promotes cell survival. These phosphorylations, being blocked by LY294002, are attributable to activation of the PI3K. This results in agreement with very recent data showing that in cultured embryonic neurons, the VLDL receptors are coupled to the PI3K-dependent signaling cascade. Thus, we propose that VLDLs induce proliferation of vascular SMCs by acting via the VLDL receptors and by a consecutive alteration in intracellular signaling pathways, resulting in inhibition of the CREB pathway and activation of NFAT (Figure 7) .
VLDLs induce a calcineurin-dependent, PI3K-dependent translocation of NFATc3 to the nucleus, which coincides with proliferation, because both phenomenon are inhibited by CsA and LY294002. Furthermore, VLDLs induce phosphorylation of GSK-3␤ and thus inhibit its activity, which is to phosphorylate and export NFAT from the nucleus. Both nuclear translocation and inhibition of export will favor NFAT activity. Our results indicate that NFATc3 is present in aortic SMCs as in cerebral artery 21, 31 and that NFATc4 is induced in proliferating cells only. This is consistent with the fact that mice lacking NFATc3/c4 genes died with defects in vascular wall assembly. 32 Other studies on passaged SMCs reported the presence of NFATc1 and NFATc2. 33 Rapamycin very effectively prevented VLDL-induced proliferation, in agreement with previous data showing that it inhibits proliferation of vascular SMCs in vitro and in vivo, 34, 35 but rapamycin did not prevent VLDL-induced NFAT translocation (data not shown). The complex rapamycin/FKPB12 directly arrests cell cycle progression by acting on mTOR (mammalian target of rapamycin). 36 Activation of calcineurin requires a sustained increase in Ca 2ϩ . In our hands, VLDL did not increase [Ca 2ϩ ] i immediately when applied by the overflow technique, 37 at the opposite of data reporting a maximal elevation in [Ca 2ϩ ] i in a few seconds by all lipoproteins. 5 However, incubation with VLDL for several hours resulted in prolongation of Ca 2ϩ release from the ATP-sensitive pool because of a slower rate of clearance of Ca 2ϩ . Activation of phospholipase C by PIP3 and production of IP3 will also favor the increase in cytosolic Ca 2ϩ either directly by activation of the IP3R or indirectly via the capacitative Ca 2ϩ current (store-operated channel). Interestingly, the VLDL-induced blockade of the ryanodinesensitive Ca 2ϩ pool observed on the short-term resulted in long-term alteration of protein expression. Indeed, after 2 to 3 days of VLDL treatment, SERCA2a and RyR were lost (online Figure 1) .
In the presence of VLDL, CREB is dephosphorylated. Phosphorylation of CREB was shown to be coupled to Ca 2ϩ entry through the voltage-gated L-type channels, 18 and the present results show that pCREB is associated with a quiescent/differentiated phenotype of SMC. CREB dephosphorylation is probably the result of VLDL-induced inhibition of the Ca 2ϩ -induced Ca 2ϩ release mechanism and is associated with SMC proliferation. Diltiazem and ryanodine have no effect on VLDL-induced proliferation, because the Ca 2ϩ -induced Ca 2ϩ release mechanism is already blocked. Others have shown that p-CREB recruits p53, the tumor suppressor gene. 29 Interestingly, a decrease in expression of p53 was observed with VLDL. The role of p53 in regulating prolifer- ation in atherosclerosis or restenosis after angioplasty is highly controversial, 38 but loss of p53 accelerates neointimal lesions of vein bypass grafts. 39 Furthermore, apoE/p53 double-knockout mice had a significant increase in cell proliferation and atherosclerotic lesions induced by hyperlipidemia. 40 The exact nature of the alteration in Ca 2ϩ movement is not clear but seems to be indirect, because several hours were needed to observe an effect of VLDL on Ca 2ϩ signaling. VLDLs are lipoproteins enriched in triglycerides and relatively poor in phospholipids, and this may alter the composition of cellular membranes. Alterations in the lipid composition of biological membranes, including sarcoplasmic reticulum (SR), have been shown to modulate the function of integral proteins and especially of SERCA. 41, 42 Alternatively, activation of protein kinase C (PKC), a second substrate of PDK1, may also account for this effect, because PKC activation decreases SR Ca 2ϩ transport 43 and reduces the storage capacity of the sarcoplasmic reticulum Ca 2ϩ pool. 44 Furthermore, PKC can inhibit spontaneous Ca 2ϩ release in SMCs by lowering the Ca 2ϩ sensitivity of RyR channels 45, 46 or inhibition of Ca 2ϩ influx through L-type channels. 47 In conclusion, we have shown that VLDLs induce proliferation of SMCs by activating the PI3 kinase cascade, resulting in alteration of intracellular calcium homeostasis and in NFAT translocation into the nucleus. VLDLs also inhibit the ryanodine-sensitive store and CREB phosphorylation, additionally favoring proliferation.
